FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381684367> ?p ?o ?g. }

• W4381684367 abstract "Abstract Study question Does CultActive© improve reproductive outcomes of ICSI cycles in cases of low fertilization rate and normal fertilization rate? Summary answer The application of CultActive© after ICSI improves fertilization rates only in clinical indication of fertilization failure. What is known already Oocyte activation deficiency is attributed in the majority of cases to fertilization failure in ICSI cycles, and these can be corrected by increasing initial levels of calcium (Ca2+) using assisted oocyte activation techniques (AOA), such as the use of Ca2+ ionophores. These agents enhance intracellular calcium release and increase the membrane permeability facilitating the influx of extracellular Ca2+, which initiates the activation cascade. Previous results suggest that Ca2+ ionophore treatment can increase the live birth rate after failed ICSI cycles in couples with poor fertilization rates, embryo developmental arrest, and also increase the number of good quality embryos. Study design, size, duration This was a retrospective observational study. There were 30 patients included and the first group consisted of 30 ICSI cycles, 231 oocytes and 56 embryos (without AOA). The second group consisted of the same patients (n = 30) with 30 ICSI cycles using AOA, 219 oocytes and 47 embryos. Subgroups were defined according to clinical indications (normal fertilization rate group: ≥ 65 % and low fertilization rate group: &lt;65% ). All data was collected from January-December 2022. Participants/materials, setting, methods 450 oocytes were assessed in the study. 231 oocytes belonged to the pre-AOA and 219 belonged to the AOA. The oocytes were exposed for 15 minutes after ICSI in a solution containing the Ca2+ ionophore A23187, CultActive© (Gynemed, Germany). Fertilization, good quality blastocyst formation and pregnancy rate were analyzed.Good quality blastocyst were defined as ≥ 3BB. Statistical significance was analyzed using the Paired Student T test (p &lt; 0.05 was considered statistically significant). Main results and the role of chance The cohort of patients with normal fertilization rate (without clinical indications),was not significantly different. The AOA treatment gave a fertilization rate of 61% compared to 71% of the control cycles (p = 0.1398). There was no increase in the number of good quality blastocysts formation when the study group was compared to the control (p = 0.1660). In the cohort of patients with an indication of low fertilization, a significantly higher fertilization rate was recorded compared to the control (51% and 37%, respectively p = 0.0238). There were no significant difference in the quantity of good quality blastocysts compared with the control (p = 0.3328). Regardless of normal or low fertilization rates there was no significant difference in pregnancy rate when CultActive© was used in treatment (p &gt; 0.05). Limitations, reasons for caution There are limitations in our study. First, the retrospective design and limited study population are major limitations. The data should be interpreted cautiously in the subgroup analyses due to potential bias, specifically the small population in the group without clinical indication. Wider implications of the findings AOA was only beneficial for couples with poor fertilization. Embryo quality and pregnancy rate did not improve with CultActiveive©. External variation was minimized by using the same patients in each cohort. This suggests AOA should not be used without clinical indication or for poor embryo quality/blastulation rate. Trial registration number not applicable" @default.
• W4381684367 created "2023-06-23" @default.
• W4381684367 creator A5005244612 @default.
• W4381684367 creator A5020799070 @default.
• W4381684367 creator A5039722318 @default.
• W4381684367 creator A5049892406 @default.
• W4381684367 creator A5068054114 @default.
• W4381684367 creator A5083149494 @default.
• W4381684367 creator A5090800338 @default.
• W4381684367 date "2023-06-01" @default.
• W4381684367 modified "2023-09-27" @default.
• W4381684367 title "P-218 Does Artificial Oocyte Activation (AOA) improve the outcome beyond fertilization rate in ICSI cycles?" @default.
• W4381684367 doi "https://doi.org/10.1093/humrep/dead093.576" @default.
• W4381684367 hasPublicationYear "2023" @default.
• W4381684367 type Work @default.
• W4381684367 citedByCount "0" @default.
• W4381684367 crossrefType "journal-article" @default.
• W4381684367 hasAuthorship W4381684367A5005244612 @default.
• W4381684367 hasAuthorship W4381684367A5020799070 @default.
• W4381684367 hasAuthorship W4381684367A5039722318 @default.
• W4381684367 hasAuthorship W4381684367A5049892406 @default.
• W4381684367 hasAuthorship W4381684367A5068054114 @default.
• W4381684367 hasAuthorship W4381684367A5083149494 @default.
• W4381684367 hasAuthorship W4381684367A5090800338 @default.
• W4381684367 hasBestOaLocation W43816843671 @default.
• W4381684367 hasConcept C105702510 @default.
• W4381684367 hasConcept C16685009 @default.
• W4381684367 hasConcept C179265757 @default.
• W4381684367 hasConcept C196843134 @default.
• W4381684367 hasConcept C2776690073 @default.
• W4381684367 hasConcept C2778278907 @default.
• W4381684367 hasConcept C512716672 @default.
• W4381684367 hasConcept C54355233 @default.
• W4381684367 hasConcept C71924100 @default.
• W4381684367 hasConcept C86803240 @default.
• W4381684367 hasConcept C88972607 @default.
• W4381684367 hasConceptScore W4381684367C105702510 @default.
• W4381684367 hasConceptScore W4381684367C16685009 @default.
• W4381684367 hasConceptScore W4381684367C179265757 @default.
• W4381684367 hasConceptScore W4381684367C196843134 @default.
• W4381684367 hasConceptScore W4381684367C2776690073 @default.
• W4381684367 hasConceptScore W4381684367C2778278907 @default.
• W4381684367 hasConceptScore W4381684367C512716672 @default.
• W4381684367 hasConceptScore W4381684367C54355233 @default.
• W4381684367 hasConceptScore W4381684367C71924100 @default.
• W4381684367 hasConceptScore W4381684367C86803240 @default.
• W4381684367 hasConceptScore W4381684367C88972607 @default.
• W4381684367 hasIssue "Supplement_1" @default.
• W4381684367 hasLocation W43816843671 @default.
• W4381684367 hasOpenAccess W4381684367 @default.
• W4381684367 hasPrimaryLocation W43816843671 @default.
• W4381684367 hasRelatedWork W1909590713 @default.
• W4381684367 hasRelatedWork W195929562 @default.
• W4381684367 hasRelatedWork W2037533250 @default.
• W4381684367 hasRelatedWork W2130263981 @default.
• W4381684367 hasRelatedWork W2134305003 @default.
• W4381684367 hasRelatedWork W2136200022 @default.
• W4381684367 hasRelatedWork W2162814346 @default.
• W4381684367 hasRelatedWork W2261789600 @default.
• W4381684367 hasRelatedWork W2531010485 @default.
• W4381684367 hasRelatedWork W2795496485 @default.
• W4381684367 hasVolume "38" @default.
• W4381684367 isParatext "false" @default.
• W4381684367 isRetracted "false" @default.
• W4381684367 workType "article" @default.